JIANGSU NHWALUOKANG PHARMACEUTICAL RES AND DEVELOPMENT CO LTD has a total of 22 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2015. It filed its patents most often in EPO (European Patent Office), Republic of Korea and United States. Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and environmental technology are NICOX SA, FRANKLIN RICHARD and ABBOTT GMBH & AMP CO KG.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 7 | |
#2 | Republic of Korea | 3 | |
#3 | United States | 3 | |
#4 | Canada | 2 | |
#5 | China | 2 | |
#6 | Israel | 2 | |
#7 | Brazil | 1 | |
#8 | Hungary | 1 | |
#9 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals | |
#3 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Wang Tao | 19 |
#2 | Li Qingeng | 19 |
#3 | Liao Jian | 10 |
#4 | Ren Liang | 9 |
#5 | Xu Xiangqing | 8 |
#6 | Duan Chen | 6 |
#7 | Li Changwen | 6 |
#8 | Hao Chao | 6 |
#9 | Chen Gang | 5 |
#10 | Zeng Lingguo | 4 |
Publication | Filing date | Title |
---|---|---|
CN111712501A | Benzodiazepine derivative hydrochloride, crystal form, preparation method and application thereof | |
US2019322698A1 | Water-soluble allopregnenolone derivative and use thereof | |
CA3031458A1 | Vortioxetine analogue and use and preparation thereof | |
US2018297958A1 | Etomidate derivative and intermediate, preparation method and use thereof | |
EP3162804A1 | New benzodiazepine derivative and use thereof | |
EP3109242A1 | Water-soluble taxane derivatives and uses thereof | |
EP3109229A1 | Water-soluble propofol derivatives and uses thereof |